Arcadia Biosciences, Inc. (RKDA)

Arcadia Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	5.41	5.33	7.42	6.78	8.03	1.17
Revenue Growth (YoY)	-26.92%	-28.15%	9.41%	-15.61%	587.25%	-20.15%
Cost of Revenue	3.57	3.3	6.1	8.71	5.2	0.89
Gross Profit	1.84	2.03	1.32	-1.93	2.84	0.28
Selling, General & Admin	13.87	14.51	15.04	22.94	16.47	13.57
Research & Development	1.3	1.39	1.51	3.89	7.96	7.1
Other Operating Expenses	0.13	0.07	-1.15	6.98	-8.81	0.71
Operating Expenses	15.3	15.97	15.39	33.81	15.61	21.37
Operating Income	-13.46	-13.94	-14.08	-35.74	-12.78	-21.09
Interest Expense / Income	0	0	0	0.02	0.05	0.01
Other Expense / Income	-6.45	0.04	1.29	-21.1	-8.05	7.71
Pretax Income	-7.01	-13.97	-15.36	-14.66	-4.78	-28.8
Income Tax	0.01	0.01	0.01	0	-0.12	0
Net Income	-7.02	-13.98	-15.38	-14.66	-4.66	-28.81
Shares Outstanding (Basic)	1	1	1	1	0	0
Shares Outstanding (Diluted)	1	1	1	1	0	0
Shares Change	57.53%	106.37%	12.66%	113.68%	56.51%	68.94%
EPS (Basic)	-5.05	-11.30	-25.65	-27.56	-18.80	-181.20
EPS (Diluted)	-5.05	-11.30	-25.65	-27.56	-18.80	-181.20
Free Cash Flow	-14.95	-15.18	-13.13	-26.86	-32.55	-18.66
Free Cash Flow Per Share	-10.98	-12.28	-21.90	-50.48	-130.72	-117.30
Gross Margin	33.97%	38.09%	17.75%	-28.44%	35.29%	24.29%
Operating Margin	-248.77%	-261.50%	-189.77%	-527.08%	-159.05%	-1804.02%
Profit Margin	-129.74%	-262.31%	-207.28%	-216.22%	-57.94%	-2464.07%
Free Cash Flow Margin	-276.36%	-284.88%	-176.99%	-396.11%	-405.09%	-1596.15%
EBITDA	-6.05	-12.99	-14	-12.32	-3.02	-27.9
EBITDA Margin	-111.83%	-243.70%	-188.72%	-181.67%	-37.62%	-2386.31%
Depreciation & Amortization	0.96	0.98	1.36	2.32	1.71	0.9
EBIT	-7.01	-13.97	-15.36	-14.64	-4.73	-28.8
EBIT Margin	-129.59%	-262.16%	-207.09%	-215.90%	-58.90%	-2463.47%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).